Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Key Highlights
- ➤Syra Health (SYRA) Q3 revenue $2.6 million, up 52% year-over-year
- ➤Q3 net income $344,610 versus $225,902 loss a year earlier
- ➤Gross margin reached record 46.3%, up 1,340 basis points year-over-year
- ➤Q3 EBITDA turned positive at $301,725 versus $218,601 loss
- ➤Company maintains full-year 2026 profitability target after three profitable quarters
Expert Statements
Greg Alexander, CEO of Syra Health
“Q3 2026 marks our third consecutive profitable quarter, and it is the clearest evidence yet that Syra Health has become a profitable growth company.”
Greg Alexander, CEO of Syra Health
“We grew revenue 52% year-over-year to a record $2.6 million, and we did it profitably: gross margin reached 46.3%, the highest in our history, up more than 13 percentage points from a year ago.”
Greg Alexander, CEO of Syra Health
“That kind of growth paired with that kind of margin expansion doesn't happen by accident.”
Greg Alexander, CEO of Syra Health
“It reflects deliberate choices we have made to focus on our high-value population health solutions, pursue better-margin workforce contracts, and run the business with discipline.”
Greg Alexander, CEO of Syra Health
“The results speak to the durability of what we're building.”
Greg Alexander, CEO of Syra Health
“Through the first nine months of 2026, we generated net income of $835,831 compared with a loss of $(761,763) in the same period last year, produced $975,023 in operating cash flow, and ended the quarter with $2.4 million in cash and no long-term debt.”
Greg Alexander, CEO of Syra Health
“We are funding our own growth, including continued investment in Syrenity Enterprise, our B2B mental and behavioral health solution.”
Greg Alexander, CEO of Syra Health
“We believe the best is still ahead.”
Greg Alexander, CEO of Syra Health
“Our approval for Syrenity within the CMS ACCESS Model with our partner HealthSync is expected to become a consistent source of revenue over the next decade.”
Greg Alexander, CEO of Syra Health
“With strong momentum across our business, we remain focused on delivering full-year profitability in 2026 and creating long-term value for our customers, the communities we serve, and our shareholders.”
Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin PR Newswire
* Revenue climbed 52% year-over-year to $2.6 million in Q3 2026, the highest quarterly revenue in the Company's history. * Earnings per share (EPS) swung to $0.02 in Q3 2026, compared with a loss of $(0.02) in Q3 2025. * Gross margin reached a Company record of 46.3% in Q3 2026, up 1,340 basis points from 32.9% in Q3 2025. * EBITDA turned positive at $301,725 in Q3 2026, a $520,326 improvement from a loss of $(218,601) in Q3 2025. CARMEL, Ind., Nov. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the third quarter ended September 30, 2026.
Get started
Create a free account to read the full story.